Reaction
Hypoaesthesia Facial reporting signals
As of the last recalculation, Hypoaesthesia Facial appears in 1,503 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS (PRR 12.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lisinopril And Hydrochlorothiazide Tablets | 7 | 12.4 | 12.4 |
| Lisinopril And Hydrochlorothiazide | 8 | 10.9 | 10.9 |
| Varenicline Tartrate | 60 | 10.8 | 10.8 |
| Onabotulinumtoxina | 50 | 9.2 | 9.3 |
| Glycerin, Lidocaine | 8 | 7.9 | 8.0 |
| Docosanol | 8 | 7.6 | 7.6 |
| Natalizumab | 94 | 7.6 | 7.6 |
| Ziprasidone Mesylate | 7 | 6.8 | 6.8 |
| Interferon Beta-1A | 90 | 6.8 | 6.8 |
| Desvenlafaxine Succinate | 13 | 6.7 | 6.7 |
| Interferon Beta-1B | 9 | 6.5 | 6.5 |
| Drospirenone And Ethinyl Estradiol | 20 | 6.3 | 6.3 |
| Asenapine Maleate | 3 | 4.8 | 4.8 |
| Exenatide | 17 | 4.5 | 4.5 |
| Orlistat | 7 | 3.8 | 3.8 |
| Hydrocodone Bitartrate | 10 | 3.2 | 3.2 |